“…As natural carrier systems, EVs present low immunogenicity, low toxicity, stability in the bloodstream, and efficient cell uptake due to their endogenous cellular tropism [ 13 ]. Their ability to mediate intercellular communication, especially in brain tumor progression, allows their use as a promising therapeutic and diagnostic tool [ 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 ], including the challenging treatment of gliomas [ 22 , 23 , 24 , 25 , 26 , 27 ]. Gliomas are the most frequent intrinsic tumors of the central nervous system and, by following the 2016 World Health Organization (WHO) update, encompass two principal subgroups: “nondiffuse gliomas”, showing a more circumscribed growth pattern (WHO grade I), and diffusely infiltrating gliomas (WHO grade II–IV), arising from glial cells or glial precursors [ 28 ].…”